10x Genomics stockholders elect three Class III directors at annual meeting

10x Genomics, Inc.

Sri Kosaraju, Mathai Mammen, and Shehnaaz Suliman elected as Class III directors for three-year terms.
Ernst & Young LLP ratified as independent auditor for FY2022 with 236,807,826 votes for.
Non-binding advisory vote on executive compensation approved with 218,457,617 votes for.

item 5.07

10x Genomics, Inc. filing history →

Source: SEC EDGAR

accession 0001770787-22-000032

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.